AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Vogjas M 500mg/50mg Tablet

Prescription Icon
Prescription Required

Marketer

Kiama Lifesciences

Salt Composition

Metformin (500mg) + Vildagliptin (50mg)

Overview Vogjas M 500mg/50mg Tablet

Diabex Duo 500mg/50mg tablets combine two medications to manage elevated blood glucose in individuals with type 2 diabetes. This dual action helps prevent serious diabetic complications like nephropathy and vision loss, and may lower the risk of cardiovascular events. Diabex Duo can be used as monotherapy or in conjunction with other antidiabetic agents. Optimal efficacy requires adherence to a healthy diet and regular physical activity. Dosage is individualized based on your health status, glycemic control, and other medications. Taking it with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes benefits; discontinuation should only occur under medical supervision. Effective blood sugar control reduces the likelihood of future complications. Maintaining your prescribed diet and exercise regimen is crucial. Lifestyle choices significantly impact diabetes management. Common side effects include diarrhea, nausea, vomiting, dyspepsia, headache, pharyngitis, asthenia, GERD, hyperhidrosis, and anorexia. Hypoglycemia is a potential adverse effect, particularly when used with insulin or sulfonylureas; learn to recognize and treat it. This medication is not universally suitable. Inform your physician of any history of renal, hepatic, or cardiac disease, pancreatic issues, or excessive alcohol consumption before commencing treatment. Pregnant or lactating women should seek medical advice. Interaction with other medications is possible; disclose all medications to your doctor to ensure safety. Alcohol should be minimized due to its potential to lower blood glucose. Your doctor will monitor your renal function and blood sugar levels throughout treatment.

Uses of Vogjas M 500mg/50mg Tablet

Managing type 2 diabetes

Major Benefits of Vogjas M 500mg/50mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Vogjas M 500mg/50mg tablets should be administered with a meal.

Common Side effects of Vogjas M 500mg/50mg Tablet:

  • Hypoglycemia (low blood glucose level)
  • Trembling
  • Headache
  • Dizziness
  • Nausea
  • Weakness
  • Gastro-esophageal reflux disease
  • Increased sweating
  • Decreased appetite

How to use Vogjas M 500mg/50mg Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Vogjas M 500mg/50mg tablets should be administered with a meal.

How Vogjas M 500mg/50mg Tablet works:

Each Vogjas M 500mg/50mg tablet contains a dual antidiabetic formulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol ingestion and Vogjas M 500mg/50mg Tablet use is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Vogjas M 500mg/50mg Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Use of Vogjas M 500mg/50mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Vogjas M 500mg/50mg tablets cautiously, as dosage modification may be necessary. Physician consultation is advised.

LiverLiverUNSAFE

Use of Vogjas M 500mg/50mg tablets is likely inadvisable for individuals with hepatic impairment and should be omitted. Medical advice is recommended.

What if you forget to take Vogjas M 500mg/50mg Tablet :

Should you forget to take your Vogjas M 500mg/50mg Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Vogjas M 500mg/50mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Vogjas M 500mg/50mg Tablet

Vogjas M 500mg/50mg Tablets rarely cause hypoglycemia by themselves; however, insufficient caloric intake while using this medication may lead to low blood sugar. Hypoglycemia symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, and shakiness. These symptoms are more pronounced if meals are missed or delayed, alcohol is consumed, excessive exercise occurs, or other antidiabetic medications are taken concurrently. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Nausea and vomiting are possible side effects of Vogjas M 500mg/50mg Tablet. If vomiting occurs, sip small amounts of water or other fluids frequently. Consult your doctor if vomiting continues or you experience dehydration symptoms such as dark, strong-smelling urine and infrequent urination. Do not take other medications without your doctor's approval.
Vogjas M 500mg/50mg Tablet is contraindicated in patients allergic to its components or excipients, and those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Vogjas M 500mg/50mg tablets combine the anti-diabetic medications metformin (a biguanide) and vildagliptin. Metformin reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. Vildagliptin, a DPP-4 inhibitor, boosts pancreatic insulin release. This combination is contraindicated for individuals under 18.
Vogjas M 500mg/50mg Tablets can cause lactic acidosis, a serious medical emergency involving excessive blood lactic acid (also known as Metformin-associated lactic acidosis, or MALA). This rare side effect necessitates avoiding the medication in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If experienced, discontinue Vogjas M 500mg/50mg Tablets and seek immediate medical attention.
Prolonged use of Vogjas M 500mg/50mg Tablet can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia and neurological complications.
Vogjas M 500mg/50mg Tablet is safe when used as directed by your doctor. However, even with correct dosage, side effects such as nausea, diarrhea, vomiting, stomach upset, headache, nasal congestion, sore throat, respiratory infection, and low blood sugar (especially if also taking insulin or sulphonylurea) may occur. Report any persistent issues to your physician.
Vogjas M 500mg/50mg Table...
131
MRP 160
18% off